Berkeley Home Health

Who owns Berkeley Home Health?

Berkeley Home Health is a British Healthcare company, now owned by Trinity Homecare, which acquired it in 2021 from August Equity.

About Berkeley Home Health

Berkeley Home Health is a United Kingdom home care provider that delivers round-the-clock live-in care, hourly visiting care and complex care to adults across the south of England. Headquartered in Farnham, the business supports clients with age-related needs, disability, chronic illness and post-hospital recovery, alongside palliative and dementia support, positioning itself in the premium, privately funded end of the domiciliary care market. By the close of its most recent ownership period it operated through three brands, Berkeley Home Care, Corinium Care and Fitzrovia, spanning roughly ten regionalised branches. Care quality is a central part of its positioning, with its East of England operation rated Outstanding by the Care Quality Commission and most other branches rated Good or better.

Ownership journey

Berkeley was established as a platform to build an independent, scaled provider of live-in and visiting care in the fragmented UK home care market. In 2014 August Equity backed the business through its August Equity Partners V fund, setting out an explicit buy-and-build strategy anchored on organic growth supplemented by add-on acquisitions. Over the holding period Berkeley completed eight acquisitions, consolidating regional operators into a single southern England footprint. August Equity realised the investment in August 2021, exiting via a secondary transaction after roughly seven years of ownership.

Under PE ownership

Under August Equity's ownership Berkeley moved from a single operator to a multi-brand group, integrating eight acquired businesses with organic branch openings to become a scale player in southern England. The consolidation brought the Berkeley Home Care, Corinium Care and Fitzrovia brands under one platform, extending the service mix across live-in, visiting, introductory and complex care. This growth was paired with a focus on regulatory quality, evidenced by an Outstanding CQC rating at its East of England branch and Good or better ratings across the remaining network. By exit the company had established a strong regional presence built on both acquisitive and organic expansion.